Cipla informs about credit rating

16 May 2017 Evaluate

Cipla has informed that Credit Analysis and Research (CARE) has reaffirmed a CARE A1+ rating to the various existing short-term bank facilities. The Company is not availing long-term bank facilities and accordingly the rating for long-term bank facilities has been withdrawn.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1347.70 -6.55 (-0.48%)
23-Apr-2024 15:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1483.75
Dr. Reddys Lab 5947.30
Cipla 1347.70
Zydus Lifesciences 958.90
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.